Answers are grounded in this paper and cite their sources.
Secondary hyperparathyroidism may develop in the presence of hypovitaminosis D in order to maintain calcium homeostasis. We conducted a cross-sectional analysis in a cohort of 371 patients, identifying secondary hyperparathyroidism in 65 patients. This high prevalence (17.5%) was in part justified by the high prevalence of hypovitaminosis D (77.4%) in the whole sample, but we also identified an independent association with the use of tenofovir.
No takes yet. Share an insight, caveat, or question.
Pocaterra et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: